Pharmacokinetic profile and safety of adjusted doses of darunavir/ritonavir with rifampicin in people living with HIV. Ebrahim, I., Maartens, G., Wiesner, L., Orrell, C., Smythe, W., & McIlleron, H. Journal of Antimicrobial Chemotherapy, 75(4):1019–1025, jan, 2020.
Pharmacokinetic profile and safety of adjusted doses of darunavir/ritonavir with rifampicin in people living with HIV [link]Paper  doi  bibtex   
@article{Ebrahim2020,
author = {Ebrahim, Ismaeel and Maartens, Gary and Wiesner, Lubbe and Orrell, Catherine and Smythe, Wynand and McIlleron, Helen},
doi = {10.1093/jac/dkz522},
file = {:C$\backslash$:/Users/01462563/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Ebrahim et al. - 2020 - Pharmacokinetic profile and safety of adjusted doses of darunavirritonavir with rifampicin in people living with.pdf:pdf},
issn = {0305-7453},
journal = {Journal of Antimicrobial Chemotherapy},
keywords = {fund{\_}not{\_}ack,original},
mendeley-tags = {fund{\_}not{\_}ack,original},
month = {jan},
number = {4},
pages = {1019--1025},
pmid = {31942627},
title = {{Pharmacokinetic profile and safety of adjusted doses of darunavir/ritonavir with rifampicin in people living with HIV}},
url = {https://academic.oup.com/jac/advance-article/doi/10.1093/jac/dkz522/5702186},
volume = {75},
year = {2020}
}

Downloads: 0